Clonazepam in Pregnancy: Risks, Alternatives & Management
Clonazepam (benzodiazepine) is generally avoided in pregnancy (FDA Category D — positive evidence of risk).
Risks
- First trimester: Cleft lip/palate, cardiac defects (conflicting data; absolute risk low but present).
- Third trimester: Neonatal floppy infant syndrome (hypotonia, hypothermia, feeding difficulty, respiratory depression), withdrawal (irritability, tremor, seizures).
- Breastfeeding: Excreted in milk; infant sedation, poor feeding.
If Benefits Outweigh Risks (Rare)
- Severe refractory epilepsy or panic disorder unresponsive to safer alternatives.
- Lowest effective dose, shortest duration.
- Folic acid 4 mg/day (neural tube protection).
- Serial ultrasounds (anatomy, growth).
- Neonatal monitoring ≥72 hrs for withdrawal.
- Avoid 3rd trimester if possible.
Preferred Alternatives
- Seizures: Lamotrigine, levetiracetam (pregnancy registries favorable).
- Anxiety: Sertraline, escitalopram (SSRIs first-line); CBT.
- Insomnia: CBT-I, sleep hygiene.
Never stop abruptly — taper under supervision. Preconception planning ideal.
Pregnancy & Health - Related Articles
- Pregnancy Dating: Calculating Gestational Age from Conception Date
- Pregnancy and Periods: Why You Don't Menstruate When Pregnant
- Fetal Mummification: Rare Phenomenon in Deceased Pregnant Women
- Dizziness, Cramps, and Late Period: Possible Causes and When to See a Doctor
- Pregnancy After Insemination: Optimal Timing for Conception
- Uterine Pulsations at 34 Weeks Pregnancy: Normal Physiology Explained
- 3 cm Dilated: What It Means & How Much Longer Until Delivery
